These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19602559)

  • 1. Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.
    Bredella MA; Torriani M; Thomas BJ; Ghomi RH; Brick DJ; Gerweck AV; Miller KK
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3995-4002. PubMed ID: 19602559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women.
    Bredella MA; Torriani M; Ghomi RH; Thomas BJ; Brick DJ; Gerweck AV; Harrington LM; Miller KK
    Obesity (Silver Spring); 2011 May; 19(5):911-6. PubMed ID: 21151017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls.
    Misra M; Bredella MA; Tsai P; Mendes N; Miller KK; Klibanski A
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E385-92. PubMed ID: 18544645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women.
    Bredella MA; Ghomi RH; Thomas BJ; Miller KK; Torriani M
    J Magn Reson Imaging; 2010 Aug; 32(2):388-93. PubMed ID: 20677267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.
    Cordido F; Garcia-Buela J; Sangiao-Alvarellos S; Martinez T; Vidal O
    Mediators Inflamm; 2010; 2010():434562. PubMed ID: 20150954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity.
    Sinha R; Dufour S; Petersen KF; LeBon V; Enoksson S; Ma YZ; Savoye M; Rothman DL; Shulman GI; Caprio S
    Diabetes; 2002 Apr; 51(4):1022-7. PubMed ID: 11916921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
    Carmichael JD; Danoff A; Milani D; Roubenoff R; Lesser ML; Livote E; Reitz RE; Ferris S; Kleinberg DL
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):169-77. PubMed ID: 16886956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationships of spontaneous growth hormone axis activity, body fat, and serum lipids in healthy elderly women and men.
    O'Connor KG; Harman SM; Stevens TE; Jayme JJ; Bellantoni MF; Busby-Whitehead MJ; Christmas C; Münzer T; Tobin JD; Roy TA; Cottrell E; St Clair C; Pabst KM; Blackman MR
    Metabolism; 1999 Nov; 48(11):1424-31. PubMed ID: 10582552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramyocellular lipid and insulin resistance: differential relationships in European and African Americans.
    Ingram KH; Lara-Castro C; Gower BA; Makowsky R; Allison DB; Newcomer BR; Munoz AJ; Beasley TM; Lawrence JC; Lopez-Ben R; Rigsby DY; Garvey WT
    Obesity (Silver Spring); 2011 Jul; 19(7):1469-75. PubMed ID: 21436797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.
    Utz AL; Yamamoto A; Sluss P; Breu J; Miller KK
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4033-40. PubMed ID: 18647804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.
    Makimura H; Stanley T; Mun D; You SM; Grinspoon S
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4254-60. PubMed ID: 18765508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of intramyocellular lipid to insulin sensitivity may differ with ethnicity in healthy girls and women.
    Lawrence JC; Newcomer BR; Buchthal SD; Sirikul B; Oster RA; Hunter GR; Gower BA
    Obesity (Silver Spring); 2011 Jan; 19(1):43-8. PubMed ID: 20559297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and Type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity.
    Misra A; Sinha S; Kumar M; Jagannathan NR; Pandey RM
    Diabet Med; 2003 May; 20(5):361-7. PubMed ID: 12752484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period.
    Perotti M; Perra S; Saluzzi A; Grassi G; Pincelli AI
    Horm Metab Res; 2013 Sep; 45(10):748-53. PubMed ID: 23913118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.
    Bredella MA; Gerweck AV; Lin E; Landa MG; Torriani M; Schoenfeld DA; Hemphill LC; Miller KK
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3864-72. PubMed ID: 23824419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
    Utz AL; Yamamoto A; Hemphill L; Miller KK
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2507-14. PubMed ID: 18445664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/Obesity.
    Dichtel LE; Corey KE; Haines MS; Chicote ML; Kimball A; Colling C; Simon TG; Long MT; Husseini J; Bredella MA; Miller KK
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3624-e3632. PubMed ID: 35779256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Low-Fat Vegan Diet on Body Weight, Insulin Sensitivity, Postprandial Metabolism, and Intramyocellular and Hepatocellular Lipid Levels in Overweight Adults: A Randomized Clinical Trial.
    Kahleova H; Petersen KF; Shulman GI; Alwarith J; Rembert E; Tura A; Hill M; Holubkov R; Barnard ND
    JAMA Netw Open; 2020 Nov; 3(11):e2025454. PubMed ID: 33252690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.